#ORPH Open Orphan Plc – Capital Markets Day October 20, 2022 – Posted in: Blog, Open Orphan (ORPH)
Open Orphan plc (AIM: ORPH), (to be renamed hVIVO plc (AIM: HVO) effective 26 October 2022), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces it will be holding a Capital Markets Day for analysts, institutional investors and media on Wednesday 2 November 2022 at 9.30 am – 12.00 pm (GMT). The event, which will be chaired by CEO Yamin ‘Mo’ Khan,…
Continue reading